CGMP RE-SUPPLY OF HPV 16L1/16RG1

NIH RePORTER · NIH · N02 · $855,278 · view on reporter.nih.gov ↗

Abstract

The purpose of this task order is to re-supply recombinant human papillomavirus type 16 chimeric L1/L2 virus-like particles (VLPs) for use as a vaccine (HPV16L1/16RG1 VLP vaccine) in ongoing human clinical trials, through the tasks identified in the Statement of Work, dated 12/18/2020.

Key facts

NIH application ID: 10490563
Project number: 75N91019D00027-0-759102100001-1
Recipient: KINDRED BIO
Principal Investigator: KEVIN LIN
Activity code: N02
Funding institute: NIH
Fiscal year: 2021
Award amount: $855,278
Award type: —
Project period: 2021-02-26 → 2022-02-25